132 related articles for article (PubMed ID: 33184029)
1. Natural P-gp inhibitor EGCG improves the acteoside absorption in Caco-2 cell monolayers and increases the oral bioavailability of acteoside in rats.
Zhou F; Huang W; Xu T; Wu L; Chen Q; Peng J; Liu X; Lu B
Food Chem Toxicol; 2020 Dec; 146():111827. PubMed ID: 33184029
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, Biodistribution, Excretion and Plasma Protein Binding Studies of Acteoside in Rats.
Wen Y; Huo S; Zhang W; Xing H; Qi L; Zhao D; Li N; Xu J; Yan M; Chen X
Drug Res (Stuttg); 2016 Mar; 66(3):148-53. PubMed ID: 26241371
[TBL] [Abstract][Full Text] [Related]
3. Bioaccessibility and Absorption Mechanism of Phenylethanoid Glycosides Using Simulated Digestion/Caco-2 Intestinal Cell Models.
Zhou F; Huang W; Li M; Zhong Y; Wang M; Lu B
J Agric Food Chem; 2018 May; 66(18):4630-4637. PubMed ID: 29687721
[TBL] [Abstract][Full Text] [Related]
4. Transepithelial transport of theasinensins through Caco-2 cell monolayers and their absorption in Sprague-Dawley rats after oral administration.
Qiu J; Kitamura Y; Miyata Y; Tamaru S; Tanaka K; Tanaka T; Matsui T
J Agric Food Chem; 2012 Aug; 60(32):8036-43. PubMed ID: 22831633
[TBL] [Abstract][Full Text] [Related]
5. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi JS; Piao YJ; Kang KW
Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance-associated protein 2 (MRP2) is an efflux transporter of EGCG and its metabolites in the human small intestine.
Kikuchi T; Hayashi A; Ikeda N; Morita O; Tasaki J
J Nutr Biochem; 2022 Sep; 107():109071. PubMed ID: 35636688
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of savaside A, acteoside, and isoacteoside in rat plasma by UHPLC-MS/MS: Comparative pharmacokinetic and bioavailability characteristics of Monochasma savatieri via different routes of administration.
Feng B; Song Y; Xu Q; Xu P; Zeng Q; Shan B; Liu K; Su D
J Sep Sci; 2018 Dec; 41(24):4408-4418. PubMed ID: 30307101
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon YJ; Morris ME
Mol Pharm; 2007; 4(6):865-72. PubMed ID: 17970592
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols.
Jodoin J; Demeule M; Beliveau R
Biochim Biophys Acta; 2002 Jan; 1542(1-3):149-59. PubMed ID: 11853888
[TBL] [Abstract][Full Text] [Related]
11. Determination of acteoside in Cistanche deserticola and Boschniakia rossica and its pharmacokinetics in freely-moving rats using LC-MS/MS.
Wu YT; Lin LC; Sung JS; Tsai TH
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 844(1):89-95. PubMed ID: 16890504
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of acteoside following single dose intragastric and intravenous administrations in dogs.
Zhang W; Huo SX; Wen YL; Xing H; Zhang Q; Li N; Zhao D; Sun XL; Xu J; Yan M; Chen XJ
Chin J Nat Med; 2015 Aug; 13(8):634-40. PubMed ID: 26253497
[TBL] [Abstract][Full Text] [Related]
13. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra.
Cao J; Chen X; Liang J; Yu XQ; Xu AL; Chan E; Wei D; Huang M; Wen JY; Yu XY; Li XT; Sheu FS; Zhou SF
Drug Metab Dispos; 2007 Apr; 35(4):539-53. PubMed ID: 17220245
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective property of 20(S)-protopanaxadiol ocotillol type epimers affects its absorption and also the inhibition of P-glycoprotein.
Wang W; Wu X; Wang L; Meng Q; Liu W
PLoS One; 2014; 9(6):e98887. PubMed ID: 24887182
[TBL] [Abstract][Full Text] [Related]
15. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.
Woo JS; Lee CH; Shim CK; Hwang SJ
Pharm Res; 2003 Jan; 20(1):24-30. PubMed ID: 12608532
[TBL] [Abstract][Full Text] [Related]
17. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine.
Liu ZQ; Jiang ZH; Liu L; Hu M
Pharm Res; 2006 Dec; 23(12):2768-80. PubMed ID: 17063398
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract.
Zhao M; Qian D; Liu P; Shang EX; Jiang S; Guo J; Su SL; Duan JA; Du L; Tao J
Biomed Chromatogr; 2015 Dec; 29(12):1842-8. PubMed ID: 26031219
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans.
Obermeier M; Yao M; Khanna A; Koplowitz B; Zhu M; Li W; Komoroski B; Kasichayanula S; Discenza L; Washburn W; Meng W; Ellsworth BA; Whaley JM; Humphreys WG
Drug Metab Dispos; 2010 Mar; 38(3):405-14. PubMed ID: 19996149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
